| ||
Analysts: Arena's diet drug still a toss-up call MarketWatch (blog) Analysts are still skeptical whether Arena Pharmaceuticals' long-awaited diet drug lorcaserin can win FDA approval, according to notes released Thursday. The FDA originally rejected lorcaserin in 2010, citing concerns that some animal studies indicated ... See all stories on this topic » | ||
Overweight, Obese Adults Use Electronic Device to Stick to Diet, Exercise MarketWatch (press release) Study Highlights: , Mar 15, 2012 (GlobeNewswire via COMTEX) -- Overweight and obese adults using an electronic device that provided daily messages did better at staying on diet and exercise programs. -- Those using the device were more successful in ... See all stories on this topic » | ||
New Clues to Link Between Fatty Diet, Colon Cancer U.S. News & World Report THURSDAY, March 15 (HealthDay News) -- Researchers say they've discovered clues about how a fatty diet increases the risk of colon cancer. "There have always been questions about why things like diet and obesity are independent risk factors for colon ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment